Start Date
May 23, 2022
Primary Completion Date
May 23, 2022
Study Completion Date
May 23, 2022
Roxadustat
HIF-PH inhibitor for treatment of anemia in CKD
Icahn School of Medicine at Mount Sinai (ISMMS) - The Mount Sinai Hospital (MSH), New York
Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago
University of Nebraska Medical Center, Omaha
Investigative site, San Antonio
Lead Sponsor
Collaborators (1)
AstraZeneca
INDUSTRY
FibroGen
INDUSTRY